pyridine/癲癇性発作

The present invention relates to a class of substituted imidazo-pyridine derivatives and to their use in therapy. More particularly, this invention is concerned with imidazo[4,5-b]pyridine analogues which are substituted in the 3-position by a substituted phenyl ring. These compounds are ligands for

The present invention relates to a class of substituted imidazopyridine derivatives and to their use in therapy. More particularly, this invention is concerned with imidazo[1,2-.alpha.]pyridine analogues which are substituted in the 3-position by a substituted phenyl ring. These compounds are

CROSS REFERENCE TO RELATED APPLICATIONS This application is a U.S. National Phase application under 35 U.S.C. .sctn. 371 of PCT Application No. PCT/GB03/02236, filed May 23, 2003, which claims priority under 35 U.S.C. .sctn. 119 from GB Application No. 0212048.3, filed May 24, 2002. The present

CROSS REFERENCE TO RELATED APPLICATIONS This application is a U.S. National Phase application under 35 U.S.C. .sctn. 371 of PCT Application No. PCT/GB03/02250, filed May 23, 2003, which claims priority under 35 U.S.C. .sctn. 119 from GB Application No. 0212049.1, filed May 24, 2002. The present

The present invention relates to a class of substituted pyrazolo-pyridine derivatives and to their use in therapy. More particularly, this invention is concerned with substituted and/or ring-fused pyrazolo[3,4-b]pyridine derivatives which are ligands for GABA.sub.A receptors and are therefore useful

FIELD OF THE INVENTION This invention relates to substituted 4-oxy-pyridines and more specifically to such compounds that bind to the benzodiazepine site of GABA.sub.A receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in

FIELD OF THE INVENTION This invention relates to substituted 4-oxy-pyridines and more specifically to such compounds that bind to the benzodiazepine site of GABA.sub.A receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in

The present invention relates to a class of substituted pyrazolo-pyridine derivatives, and to their use in therapy. More particularly, this invention is concerned with substituted pyrazolo[4,3-c]pyridin-3-one analogues which are ligands for GABA.sub.A receptors and are therefore useful in the

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to heterocyclic amino substituted heteroaryl fused pyridines, and more specifically to such compounds that selectively bind to GABAa receptors. This invention also relates to pharmaceutical compositions comprising such

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to heterocyclic amino substituted heteroaryl fused pyridines, and more specifically to such compounds that selectively bind to GABAa receptors. This invention also relates to pharmaceutical compositions comprising such

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to certain heterocyclic amino substituted heteroaryl fused pyridines which selectively bind to GABAa receptors. This invention also relates to pharmaceutical compositions comprising such compounds. It further relates to the

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to certain fused pyrrolecarboxanilides which selectively bind to GABAa receptors. This invention also relates to pharmaceutical compositions comprising such compounds. It further relates to the use of such compounds in

BRIEF SUMMARY OF THE INVENTION The invention relates to compounds of the formula ##STR2## wherein Q.sup.1 and the nitrogen atom taken together are a group of the formula >N--CH.sub.2 CH.sub.2 -- (a), >N--CH.sub.2 CH.sub.2 CH.sub.2 -- (b), >N--CH.dbd.CH-- (c), >N--CH.sub.2 --CH.dbd.CH--

BRIEF SUMMARY OF THE INVENTION The invention relates to compounds of the formula ##STR2## wherein Q.sup.1 and the nitrogen atom taken together are a group of the formula >N--CH.sub.2 CH.sub.2 -- (a), >N--CH.sub.2 CH.sub.2 CH.sub.2 -- (b), >N--CH=CH-- (c). >N--CH.sub.2 --CH=CH-- (d).

BACKGROUND OF THE INVENTION The present invention relates to certain novel imidazo[4,5-b]pyridines useful as anxiolytic and anticonvulsant agents, by virtue of their ability to bind to the benzodiazepine receptors and inhibit electrically or chemically induced seizures. The preparation of fused